Circadian Therapeutics was founded in September 2016 as a spin-out from Oxford University with the aim to deliver benefit and value for all its stakeholders; patients, healthcare providers and investors
Circadian Therapeutics was founded in September 2016 as a spin-out from Oxford University with the aim to deliver benefit and value for all its stakeholders; patients, healthcare providers and investors. The world-leading science generated by its academic founders is the foundation for the development of therapeutic products based on the understanding of the molecular control of circadian rhythms.